Antigens

News

Related Video News

No related video news stories found.

Organic Broadcast Project

Related Videos

No related videos found.

Bostwick Therapeutics Announces Initiation of Novel Phase I/II Personalized Medicine Immunotherapy Trial for Advanced ...

Published September 5, 2008, 1:05 pm, Centre Daily Times

Bostwick Therapeutics announced today that it has received clearance from the U.S. Food and Drug Administration and the Institutional Review Board of Community Memorial Hospital, Ventura, CA., to initiate the CRITICAL (CRyotherapy and IntraTumoral Immunotherapy with immature dendritic Cells (AutoLogous)) trial, a clinical trial examining the potential of a novel combination of cryoablation and ...

Discover News | Full Story


Bostwick Therapeutics Announces Initiation of Novel Phase I/II Personalized Medicine Immunotherapy Trial for Advanced ...

Published September 5, 2008, 1:00 pm, wallstreet:online AG

Bostwick Therapeutics announced today that it has received clearance from the U.S. Food and Drug Administration

Discover News | Full Story


Phase III U.S. Pivotal Study Results On CSL Biotherapies' Afluria® Published In Vaccine - Influenza Virus Vaccine

Published September 5, 2008, 7:16 am, Medical News Today

Phase III pivotal study findings in the journal Vaccine showed that two formulations of CSL Biotherapies' influenza virus vaccine Afluria® elicited an immune response (also known as immunogenicity) in healthy adults aged 18 - About the Phase III Study The pivotal study was a National Institutes

Discover News | Full Story


Expression Genetics' EGEN-001 Named One of 10 Most Promising Oncology Products by Windhover

Published September 5, 2008, 5:00 am, PR Newswire via Yahoo! Finance

Expression Genetics, Inc. announced today that the company's novel TheraPlas® cancer drug has been selected as one of the Top 10 most promising oncology products in development available for strategic partnering.

Discover News | Full Story


Bladder Tumor Markers: From Hematuria To Molecular Diagnostics - Where Do We Stand?

Published September 5, 2008, 3:17 am, Medical News Today

UroToday.com - Bladder cancer is an extremely lethal disease occurring in a large number of patients each year. Most evaluations that result in the diagnosis of bladder cancer are initiated with the finding of either gross or microscopic hematuria. While the majority of patients with hematuria will not have bladder cancer, a sizeable proportion will.

Discover News | Full Story


Immune Responses In Disease Monitored

Published September 5, 2008, 3:17 am, Medical News Today

A recent study (doi:10.1016/j.clim.2008.06.009) published in Clinical Immunology, the official journal of the Clinical Immunology Society (CIS), describes a new method enabling the detection of multiple parameters of single human cells.

Discover News | Full Story


Diane Sherrer: Ithacan Diboun to run 100-miler for lupus research

Published September 5, 2008, 2:38 am, The Ithaca Journal

Yassine Diboun will go 100 miles on foot to help a friend in need.

Discover News | Full Story


CSL Biotherapies Announces First Shipments of Afluria(R) Thimerosal-Free Influenza Vaccine for the 2008-2009 Flu Season

Published September 4, 2008, 8:12 pm, Centre Daily Times

CSL Biotherapies, a subsidiary of one of the world's leading manufacturers of influenza vaccine, announced today that it has begun shipment of its influenza virus vaccine in the U.S. for the 2008-2009 season. CSL plans to deliver more than six million doses of Afluria and the majority of the supply will be in single-dose, thimerosal-free, pre-filled syringes.

Discover News | Full Story


CSL Biotherapies Announces First Shipments of Afluria(R) Thimerosal-Free Influenza Vaccine for the 2008-2009 Flu Season

Published September 4, 2008, 3:25 pm, wallstreet:online AG

CSL Biotherapies, a subsidiary of one of the world´s leading manufacturers of influenza vaccine,

Discover News | Full Story


CSL Biotherapies Announces First Shipments of Afluria(R) Thimerosal-Free Influenza Vaccine for the 2008-2009 Flu Season

Published September 4, 2008, 3:14 pm, Business Wire via Yahoo! Finance

KING OF PRUSSIA, Pa.----CSL Biotherapies, a subsidiary of one of the world's leading manufacturers of influenza vaccine, announced today that it has begun shipment of its influenza virus vaccine in the U.S. for the 2008-2009 season.

Discover News | Full Story



News Directory

Get started fast by using a pre-defined news directory category

Breaking News
and Top Stories
Business
Earnings, Economy, Personal Finance, and Stock Markets
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss
Politics
Congress, Supreme Court, and White House
Science
Animals, Astronomy, Biotechnology, Space, and Weather
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis
Technology
Communications, Hardware, Internet, Personal Technology, and Software
United States
and Crimes and Trials
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East


© Copyright 2005-2006 News Meme, All Rights Reserved | More News | Link Index | OSWD Design

Powered by Odin Assemble 2.5a